Omar saeb Salih

Dr. Omar saeb Salih

College of Pharmacy,Baghdad University, Baghdad, Baghdād, Iraq
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Iraqi Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
Omar saeb SalihOmar saeb Salih
Omar saeb Salih
EAEntidhar J. Al-Akkam
Entidhar J. Al-Akkam
Invasomes are newly developed types of nanovesicles. A vesicular drug delivery system is considered one of the approaches for transdermal delivery to enhance permeation and improve drug bioavailability. Ondansetron is a serotonin receptor antagonist used for treating vomiting associated with different clinical cases. The study aimed to prepare invasomal dispersions for improving permeation of ondansetron across the skin with a controlled release pattern. Twenty-seven formulas of ondansetron-loaded invasomes were prepared by a modified mechanical dispersion method. These formulas were optimized by studying the effect of variables on entrapment efficiency. Vesicle size, polydispersity, zeta potential, in-vitro release and ex-vivo permeation studies were done for the optimized formulas. The selected formula was )F25( had )88.24%±0.04 (entrapment, (317.7 nm) vesicle size, (0.29) polydispersity, and (-31.5mV) zeta potential. In-vitro release study showed That (F25) had 75% release after (12) hrs., and dissolution followed the Korsmeyer-Peppas model with anomalous diffusion. Ex-vivo permeation study showed steady-state flux was 340.2 µg/cm2.hr with no lag time using rat skin tissue. A transmission electron microscope was done to visualize the selected formula. Invasomes are considered promising drug delivery systems for transdermal delivery of ondansetron, ensuring efficient permeation with a sustained release pattern.

1 January 2024 in Journal of Research in Pharmacy
Verified
Journal Article
Open access
PDF file
Omar saeb SalihOmar saeb Salih
Omar saeb Salih
EMEntidhar Muhammed
Entidhar Muhammed
Ondansetron is a serotonin receptor antagonist for treating nausea and vomiting. Its multiple daily doses and extensive first-pass metabolism faced parenteral and oral administration challenges. The transdermal route enhances its bioavailability as it bypasses the first-pass effect. Invasome vesicles improve the skin permeation of ondansetron via its unique components, lecithin, limonene, and ethanol, which are considered efficient permeation enhancers. The current study intends to develop a gel containing ondansetron as invasomes vesicles with appropriate texture and efficient skin penetration. Two gelling agents, hydroxypropyl methylcellulose K4M and carbopol 934P, were used at two concentrations (0.5 and 1%, w/w). Formulas were evaluated regarding pH, content uniformity, viscosity, spreadability, and ex vivo permeation. The selected formula (F3), which contained ondansetron (5%, w/w) and used carbopol 934P at (0.5%, w/w), was homogeneous, with proper viscosity (21,500 ± 390 mPa.s) at rest and enough spreadability (3.4 ± 0.45 cm). The ex vivo permeation showed permeation flux (Jss) was (280.4 ± 3.5 g/cm2.h) with a shorter lag time (0.5 ± 0.1 h). Characterization studies revealed nanosized vesicles (Dav. = 202.9 ± 0.5 nm) as spherical shapes dispersed within a gel matrix. In vivo, skin irritation and histopathology studies using male Wistar albino rats demonstrated that (F3) was biocompatible, with no irritation reported for six consecutive days. In conclusion, the invasomes gel of ondansetron utilizing carbopol (0.5%, w/w) was prepared for transdermal delivery, offering effective permeation and safe application. An invasomes-loaded gel is considered a novel formulation, giving an efficient and realistic therapeutic option for treating vomiting.

1 December 2016 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
Omar saeb SalihOmar saeb Salih
Omar saeb Salih
RNRoaa Abdalhameed Nief
Roaa Abdalhameed Nief
Objective: The objective of this study is to develop a controlled release matrix tablet of candesartan cilexetil to reduce the frequency of administration,enhance bioavailability and improve patient compliance; a once daily sustained release formulation of candesartan cilexetil is desirable.Methods: The prepared tablets from F1 to F24 were evaluated with different evaluation parameters like weight variation, drug content, friability,hardness, thickness and swelling ability. In vitro release for all formulas were studied depends on the type and amount of each polymer, i.e. (16 mg,32 mg and 48 mg) respectively beside to the combination effect of polymers on the release of the drug from the tablet.Results: In vitro release showed that formula 13 had the faster release (100% after 4 h) which contained acacia (1:1) and the lowest sustain releasewas showed for F7 (73% after 8 h) which contained HPMC K100M (1:1). Formula 1 was an 89 % release after 8 h which contain eudragit RS100; F4was a 100 % release after 5 h which contain Na CMC, F10 was a 100% after 8 h which contain xanthan gum and F16 was a 100 % release after 5 hwhich contain tragacanth polymer. Formula 9 had a lower release than F7 and F8 respectively. Formula 7 can be used for sustain oral drug delivery ofcandesartan cilexetil while Formula 13 can be used in contrary as fast release tablets for faster response.Conclusion: Controlled drug delivery system is promising for less dosing and higher patient compliance.Keywords: Angiotensin II receptor antagonist, Hypertension, Matrix system, Control release.

1 January 2025 in Journal Of Advanced Pharmacy Education And Research
Verified
Journal Article
Open access
PDF file
IAIshraq K. Abbas
Ishraq K. Abbas
MHMarwah M. Hareeja
Marwah M. Hareeja
SJSaba Abdulhadi Jaber
Saba Abdulhadi Jaber
AQAdnan Burhan Qader
Adnan Burhan Qader
RMRaffah Khamis Mahal
Raffah Khamis Mahal
AHAhmed Abbas Hussein
Ahmed Abbas Hussein
Captopril aqueous solution prepared using the drug as a powder dissolved in water was stable only for approximately twenty-seven days. The present work aimed to prepare captopril as stable dry solid effervescent granules that form a suitable swallowing aqueous liquid dosage for pediatrics. Six formulas were prepared, by wet, and; fusion methods, using different ratios of citric acid and tartaric acid with potassium bicarbonate as the effervescent base. The granules evaluation was done concerning

14 January 2022 in Journal of Medical and Health Studies
Verified
Journal Article
Closed access
PDF file
Omar saeb SalihOmar saeb Salih
Omar saeb Salih
MGMowafaq M. Ghareeb
Mowafaq M. Ghareeb
MMMais Fadhel Mohammed
Mais Fadhel Mohammed
Diabetes is a metabolic condition that affects how the body utilizes digested food for growth and energy. The majority of the food we consume is broken down into glucose, which is the form of sugar in our blood. Glucose is the body's primary fuel source. The solubility of glibenclamide (glibenclamide), metformin, and sitagliptin were evaluated in triplicate in different pH using a water bath shaker at 37oC using the shake-flask technique. The quantity of medicine accessible for absorption is determined by the drug release. Each drug's physiochemical characteristics substantially impact release along the G.I.T. For each medication, a calibration curve and solubility measurement were performed. In the duodenum and the small intestine, glibenclamide was released more efficiently and fast than metformin and sitagliptin, which had higher pKa values than glibenclamide, i.e., the metformin and sitagliptin were released more quickly and efficiently in pH 1.2 and pH 5.8. Glibenclamide is absorbed from the stomach, if not completely.

13 January 2026 in Current Drug Therapy
Verified
Journal Article
Closed access
LHLina S. Hussein
Lina S. Hussein
Omar saeb SalihOmar saeb Salih
Omar saeb Salih
SJSaba Abdulhadi Jabir
Saba Abdulhadi Jabir
Introduction: This study investigates the process of loading itraconazole (ITCZ) into span-lastic nanovesicles, which may increase its permeability and bioavailability. The objective of this study was the formulation and characterization of itraconazole-loaded spanlastics (ITCZ -SPs). Methods: Itraconazole-loaded spanlastics (ITCZ -SPs) were formulated using the ethanol injection method. The composition of the formulation included Tween 60 as an edge activator in various ratios and Span 60 as a nonionic surfactant. These formulations employed Soluplus as a stabilizer. Particle size (PS), polydispersity index (PDI), and entrapment efficiency (%EE) were all considered in the evaluation process, and then zeta potential was applied to the formulation. Additionally, this formula-tion was compared with capsules from three different companies that are currently available on the market. Results: The selected formulation showed a particle size of about 99 nm, an EE of about 81%, a PDI of about 0.263, and a zeta potential of -26.07 ± 0.89 mV. Among the tested samples, only the optimal formulation exhibited a distinct response against C. tropicalis at a 100% concentration, compared to the samples of the marketed drug. Conclusion: When combined, ITCZ-SPs significantly enhanced the solubility and permeability of ITCZ, offering a promising nanoplatform for hydrophobic drug delivery.